The stock of Cardlytics Inc (CDLX) has seen a -11.17% decrease in the past week, with a 18.83% gain in the past month, and a -38.18% decrease in the past quarter. The volatility ratio for the week is 8.08%, and the volatility levels for the past 30 days are at 11.45% for CDLX. The simple moving average for the last 20 days is -1.77% for CDLX stock, with a simple moving average of -42.20% for the last 200 days.
Is It Worth Investing in Cardlytics Inc (NASDAQ: CDLX) Right Now?
The stock has a 36-month beta value of 1.32. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for CDLX is 49.85M, and at present, short sellers hold a 16.79% of that float. On May 22, 2025, the average trading volume of CDLX was 1.13M shares.
CDLX) stock’s latest price update
The stock price of Cardlytics Inc (NASDAQ: CDLX) has plunged by -8.04 when compared to previous closing price of 1.99, but the company has seen a -11.17% decline in its stock price over the last five trading sessions. businesswire.com reported 2025-05-20 that ATLANTA–(BUSINESS WIRE)–Cardlytics Inc. (NASDAQ: CDLX) today announced the general availability of Cardlytics Rewards Platform (CRP), a new solution that provides publishers the opportunity to enhance their customer loyalty programs with card-linked offers. With CRP, a merchant with digital channels and a loyalty program can now become a publisher on the Cardlytics network and offer more value to their customers. Building on its longstanding leadership in financial media, Cardlytics is expand.
Analysts’ Opinion of CDLX
Many brokerage firms have already submitted their reports for CDLX stocks, with Evercore ISI repeating the rating for CDLX by listing it as a “In-line.” The predicted price for CDLX in the upcoming period, according to Evercore ISI is $4 based on the research report published on October 11, 2024 of the previous year 2024.
Northland Capital, on the other hand, stated in their research note that they expect to see CDLX reach a price target of $5. The rating they have provided for CDLX stocks is “Market Perform” according to the report published on August 16th, 2024.
BofA Securities gave a rating of “Underperform” to CDLX, setting the target price at $3.50 in the report published on August 15th of the previous year.
CDLX Trading at -0.64% from the 50-Day Moving Average
After a stumble in the market that brought CDLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.42% of loss for the given period.
Volatility was left at 11.45%, however, over the last 30 days, the volatility rate increased by 8.08%, as shares surge +18.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.41% lower at present.
During the last 5 trading sessions, CDLX fell by -11.17%, which changed the moving average for the period of 200-days by -74.51% in comparison to the 20-day moving average, which settled at $1.8630. In addition, Cardlytics Inc saw -50.67% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDLX starting from DeSieno Alexis, who sale 26,217 shares at the price of $1.94 back on May 15 ’25. After this action, DeSieno Alexis now owns 164,833 shares of Cardlytics Inc, valued at $50,809 using the latest closing price.
DeSieno Alexis, the Officer of Cardlytics Inc, proposed sale 26,217 shares at $1.94 during a trade that took place back on May 15 ’25, which means that DeSieno Alexis is holding shares at $50,809 based on the most recent closing price.
Stock Fundamentals for CDLX
Current profitability levels for the company are sitting at:
- -0.65 for the present operating margin
- 0.33 for the gross margin
The net margin for Cardlytics Inc stands at -0.65. The total capital return value is set at -0.75. Equity return is now at value -135.48, with -38.02 for asset returns.
Based on Cardlytics Inc (CDLX), the company’s capital structure generated 0.77 points at debt to capital in total, while cash flow to debt ratio is standing at 0.01. The debt to equity ratio resting at 3.44. The interest coverage ratio of the stock is -33.46.
Currently, EBITDA for the company is -152.53 million with net debt to EBITDA at -1.29. When we switch over and look at the enterprise to sales, we see a ratio of 0.97. The receivables turnover for the company is 2.74for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.19.
Conclusion
To sum up, Cardlytics Inc (CDLX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
